Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $111.7400 (-0.19%) ($107.6200 - $114.2000) on Wed. Aug. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.06% (three month average) | RSI | 38 | Latest Price | $111.7400(-0.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.53% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) IYT(-4%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.53% (StdDev 3.06%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $119.81 | 5 Day Moving Average | $115.06(-2.89%) | 10 Day Moving Average | $117.08(-4.56%) | 20 Day Moving Average | $119.81(-6.74%) | To recent high | -11.8% | To recent low | 18.7% | Market Cap | $1.796b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |